Mutations in human PNPLA2 gene causes neutral lipid storage disease with myopathy (NLSDM) characterized by severe accumulation of TAGs in cytoplasmic LDs in neutrophils, liver, muscle, and heart (Kobayashi et al., 2008, Schweiger et al., 2006). Here, PNPLA2 is linked to neutral lipid storage myopathy.